Integrating Evolving Evidence Into Patient-Centered Prostate Cancer Care

In this final segment, Dr. Graham and Dr. Sokolova reflect on key principles for applying evolving evidence across biochemical recurrence and metastatic castration-sensitive prostate cancer in clinical practice. The discussion synthesizes themes from the program, emphasizing the importance of balancing efficacy, long-term tolerability, and patient-centered outcomes when integrating new data into treatment decisions. Dr. Sokolova highlights the need to interpret emerging evidence within the context of trial design, guideline recommendations, and individual patient characteristics. Both experts underscore that optimal care requires ongoing reassessment as evidence matures and patient priorities evolve. The segment reinforces the value of shared decision-making, thoughtful evidence interpretation, and clinical judgment in navigating a rapidly changing treatment landscape. Overall, this closing discussion provides a cohesive framework for clinicians seeking to translate complex data into practical, individualized prostate cancer care.